Finance

Lists
000403:SHE
Pacific Shuanglin Bio-pharmacy Co Ltd
CN¥9.45
-1.05%
(-0.10) 1D
Oct 28, 3:04:06 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000403...
Open
CN¥9.55
High
CN¥9.68
Low
CN¥9.44
Mkt. cap
9.08B
Avg. vol.
5.50M
Volume
5.91M
Dividend
1.59%
Quarterly dividend
CN¥0.04
Ex-dividend date
Oct 23, 2026
P/E ratio
41.98
52-wk high
CN¥16.42
52-wk low
CN¥8.54
EPS
CN¥0.23
Shares outstanding
950.40M
No. of employees
3K
Open
CN¥9.55
High
CN¥9.68
Low
CN¥9.44
Mkt. cap
9.08B
Avg. vol.
5.50M
Volume
5.91M
Dividend
1.59%
Quarterly dividend
CN¥0.04
Ex-dividend date
Oct 23, 2026
P/E ratio
41.98
52-wk high
CN¥16.42
52-wk low
CN¥8.54
EPS
CN¥0.23
Shares outstanding
950.40M
No. of employees
3K
News stories
From web sources and news partners
About Pacific Shuanglin Bio-pharmacy Co Ltd
CEO-
Employees2.76K
Founded1993
Headquarters-
SectorBiotechnology
Website999yichun.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.01B
342.92M
486.92M
573.28M
Cost of goods sold
674.87M
223.50M
333.55M
394.35M
Cost of revenue
674.87M
223.50M
333.55M
394.35M
Research and development expenses
25.01M
10.34M
6.09M
12.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
120.55M
83.99M
76.71M
99.63M
Operating expense
162.30M
98.57M
90.31M
110.51M
Total operating expenses
837.17M
322.07M
423.86M
504.86M
Operating income
177.29M
20.85M
63.06M
68.42M
Other non operating income
-32.79K
-2.74M
2.22M
209.23K
EBT including unusual items
93.36M
29.08M
69.80M
75.37M
EBT excluding unusual items
178.56M
28.71M
70.38M
75.27M
Income tax expense
31.33M
6.34M
7.56M
8.77M
Effective tax rate
33.55%
21.82%
10.83%
11.64%
Other operating expenses
7.62M
6.17M
5.92M
4.40M
Net income
62.09M
22.97M
61.33M
66.00M
Net profit margin
6.12%
6.70%
12.60%
11.51%
Earnings per share
-
-
-
-
Interest and investment income
6.69M
15.52M
11.30M
12.19M
Interest expense
-5.39M
-4.92M
-6.20M
-5.54M
Net interest expenses
1.29M
10.60M
5.09M
6.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
210.35M
53.91M
100.07M
101.47M
Gain or loss from assets sale
-756.00K
-
135.62K
-135.62K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps